The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12625000928415p
Ethics application status
Submitted, not yet approved
Date submitted
14/06/2025
Date registered
26/08/2025
Date last updated
26/08/2025
Date data sharing statement initially provided
26/08/2025
Type of registration
Prospectively registered

Titles & IDs
Public title
Efficacy of Cognitive Behavioural Therapy In Reducing Weight And Improving Psychological Well-Being Amongst Women With Polycystic Ovary Syndrome In Hospital Sultan Abdul Aziz Shah - Phase 2
Scientific title
Efficacy of Cognitive Behavioural Therapy In Reducing Weight And Improving Psychological Well-Being Amongst Women With Polycystic Ovary Syndrome In Hospital Sultan Abdul Aziz Shah - Phase 2
Secondary ID [1] 314647 0
None
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Obesity 337808 0
Polycystic Ovarian Syndrome 337809 0
Condition category
Condition code
Diet and Nutrition 334150 334150 0 0
Obesity
Mental Health 334151 334151 0 0
Other mental health disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
This interventional study will be the second phase of the study (this application). It will be an RCT (intervention and control) to test the efficacy of the CBT (Cognitive Behavioral Therapy)-PCOS (Polycystic Ovarian Syndrome) module. The samples would be taken from the O&G clinic from Hospital Sultan Abdul Aziz Shah (HSAAS), Malaysia. The sample size required is 88 (44 each group) and will take five months (two months intervention, one month follow-up and three months follow-up). The participants will meet for 1.5 hour session per week for 8 weeks. A token of appreciation would be given to the participants after completion of the full study in order to encourage adherence to the study.

This module will involve elements of cognitive and behavioral aspects such as managing negative automatic thoughts, dietary changes, lifestyle changes, physical activity, sleep management, etc. For both phases of the study, it will be delivered by a senior clinical psychologist with over 20 years of experience.

Planned Intervention
CBT-PCOS
The module will have a total of 8 sessions. The components of these sessions were abstracted and adapted from past CBT modules. The major areas covered by the module are:
Session 1 – Introduction To the Programme
Session 2 – Dietary Changes
Session 3 – Lifestyle Modification and Movement
Session 4 – Negative Automatic Thoughts
Session 5 – Challenging Negative Automatic Thoughts
Session 6 – Coping Skills for Triggering Situations
Session 7 – Relationship And Intimacy
Session 8 – Relapse Prevention

This programme would mainly focus on medical and behavioural aspects of weight management. The TAU group would be mainly be seen by medical professionals and nutritionists from the O&G clinic. Throughout the intervention period, weekly reminders and words of encouragers will not be sent to the participants. Instead, they will only be reached out to fill in the questionnaire.
Intervention code [1] 331276 0
Behaviour
Comparator / control treatment
Participants and Recruitment
Participants who meet the inclusion criteria will be contacted and invited to join the intervention through the same O&G clinic in HSAAS. A lottery method will be used to randomly assign participants into intervention and control groups.

Control
Participants in the control group will not be receiving any additional/intervening intervention. They will instead proceed with treatment as usual (TAU) provided by the O&G clinic in HSAAS. The TAU would involve medications for weight reduction, ovulation, insulin resistance (Metformin), fertility supplementation, as well as consultation sessions with a nutritionist. This would be demonstrating the current method of treatment for women with PCOS and obesity based on the international CPG for managing PCOS.

Assessment Points
Participants in both groups will be assessed at baseline (week 0 or pretreatment assessment), 1 month, 3 months, and 6 months after the intervention.

Control group
Active

Outcomes
Primary outcome [1] 341804 0
To determine if the intervention group in CBT-PCOS improves (measured on the basis of weight loss =5%, BMI) compared to the control group during post-test and follow-up (1-month and 3-months).
Timepoint [1] 341804 0
Participants will be assessed at five time-points: pre-intervention (0 weeks), mid-intervention (4 weeks), post-intervention (8 weeks), 1-month follow-up, and 3-month follow-up.
Secondary outcome [1] 448743 0
Change in severity level of negative automatic thoughts.
Timepoint [1] 448743 0
Baseline; pre-intervention (0 weeks), post-intervention (8 weeks), 1-month follow-up, and 3-month follow-up.
Secondary outcome [2] 450572 0
Change in frequency of eating behaviour practices.
Timepoint [2] 450572 0
Baseline; pre-intervention (0 weeks), post-intervention (8 weeks), 1-month follow-up, and 3-month follow-up.
Secondary outcome [3] 450573 0
Change in level of quality of life.
Timepoint [3] 450573 0
Baseline; pre-intervention (0 weeks), post-intervention (8 weeks), 1-month follow-up, and 3-month follow-up.
Secondary outcome [4] 450574 0
Change in severity level of depression and anxiety symptoms.
Timepoint [4] 450574 0
Baseline; pre-intervention (0 weeks), post-intervention (8 weeks), 1-month follow-up, and 3-month follow-up.

Eligibility
Key inclusion criteria
• Diagnosed with PCOS (according to the Rotterdam 2003 consensus criteria)
• Has a BMI > 23 kg/m2 (according to the MoH CPG guidelines for obesity)
• Are between 18 and 45 years old
• Wishes to become pregnant (measured in demographic section of the questionnaire)
• Consented to participate in the study
• Women with an adequate literacy of the Malay language
Minimum age
18 Years
Maximum age
45 Years
Sex
Females
Can healthy volunteers participate?
No
Key exclusion criteria
• Has participated in past psychological interventions for weight management
• Diagnosed severe mental illness (e.g., psychosis)
• Obesity with another endocrine cause (e.g., Prader–Willi syndrome, hyperthyroidism)
• Ovarian tumours that lead to androgen excess adrenal diseases
• Other malformations of the internal genitalia

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
A simple lottery method would be conducted to randomise the volunteered participants into one of the two groups – intervention TAU. Equal number of pieces of paper with “1” representing intervention group or “2” representing control group, written on them would be placed into a bowl. The enumerator, not part of this study, would randomly pick out a piece of paper assigning the stated group to the participant on a name list. To minimise potential bias, the name list would be written in numerical, thus minimising the potential for the enumerator to know who the participant is based on their name, ethnicity, age, initial weight, etcetera.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
A simple lottery method would be conducted to randomise the volunteered participants into one of the two groups – intervention TAU. Equal number of pieces of paper with “1” representing intervention group or “2” representing control group, written on them would be placed into a bowl. The enumerator, not part of this study, would randomly pick out a piece of paper assigning the stated group to the participant on a name list. To minimise potential bias, the name list would be written in numerical, thus minimising the potential for the enumerator to know who the participant is based on their name, ethnicity, age, initial weight, etcetera.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment outside Australia
Country [1] 27122 0
Malaysia
State/province [1] 27122 0

Funding & Sponsors
Funding source category [1] 319211 0
Self funded/Unfunded
Name [1] 319211 0
Arman Imran Ashok (Self-funded PhD student in Universiti Putra Malaysia)
Country [1] 319211 0
Malaysia
Primary sponsor type
Individual
Name
Arman Imran Ashok (Self-funded PhD student in Universiti Putra Malaysia)
Address
Country
Malaysia
Secondary sponsor category [1] 321677 0
None
Name [1] 321677 0
Address [1] 321677 0
Country [1] 321677 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 317791 0
Ethics Committee for Research Involving Human Subjects (JKEUPM)
Ethics committee address [1] 317791 0
Ethics committee country [1] 317791 0
Malaysia
Date submitted for ethics approval [1] 317791 0
30/04/2025
Approval date [1] 317791 0
Ethics approval number [1] 317791 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 142162 0
Mr Arman Imran Ashok
Address 142162 0
Universiti Putra Malayisa, Faculty of Medicine and Health Sciences, UPM, 43400 Serdang, Selangor, Malaysia
Country 142162 0
Malaysia
Phone 142162 0
+60137793015
Fax 142162 0
Email 142162 0
Contact person for public queries
Name 142163 0
Arman Imran Ashok
Address 142163 0
Universiti Putra Malayisa, Faculty of Medicine and Health Sciences, UPM, 43400 Serdang, Selangor, Malaysia
Country 142163 0
Malaysia
Phone 142163 0
+60137793015
Fax 142163 0
Email 142163 0
Contact person for scientific queries
Name 142164 0
Arman Imran Ashok
Address 142164 0
Universiti Putra Malayisa, Faculty of Medicine and Health Sciences, UPM, 43400 Serdang, Selangor, Malaysia
Country 142164 0
Malaysia
Phone 142164 0
+60137793015
Fax 142164 0
Email 142164 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Informed consent form    JKEUPM_FORM_2.4_-_(ENGLISH_VERSION)_RESPONDENT’S_INFORMATION_SHEET_AND_INFORMED_CONSENT.pdf


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.